Results 211 to 220 of about 3,180,492 (237)
Some of the next articles are maybe not open access.
Are We Using Fibrinolytic Agents Often Enough?
Annals of Internal Medicine, 1980Excerpt The development and acceptance of new pharmacologic approaches to treatment are often painstakingly slow.
openaire +3 more sources
The combined use of fibrinolytic and anticoagulant agents
The American Journal of Cardiology, 1960Abstract The therapeutic goal in thromboembolism includes not only clot dissolution but also the maintenance of vascular patency. Clinical and experimental evidence, as well as theoretic considerations, suggest that a sequence of clot dissolution followed by a recurrence of thrombosis may occur when fibrinolytic therapy is relied upon exclusively ...
George C. Hajjar, Kenneth M. Moser
openaire +3 more sources
Fibrinolytic agents: pharmacology, indications and prescribing
Nurse Prescribing, 2011Fibrinolytic (thrombolytic) agents are used thrombolysis (clot breakdown) in several indications, including acute ST-elevation myocardial infarction, acute pulmonary embolism and acute ischaemic stroke. The pathophysiology of each condition is discussed, as well as indications for the use of fibrinolytic agents.
openaire +2 more sources
The Fibrinolytic System and Thrombolytic Agents
2001The formation of a haemostatic thrombus is a useful defence mechanism for the closure of vascular lesions. However, undesirable thrombi are also formed in closed vessels, e.g. over atherosclerotic plaques or after rupture of such plaques. It has long been assumed that the primary function of the fibrinolytic system consists of dissolving such thrombi ...
openaire +2 more sources
American Journal of Cardiology, 2004
B. Nallamothu, E. Antman, E. Bates
semanticscholar +1 more source
B. Nallamothu, E. Antman, E. Bates
semanticscholar +1 more source